Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
4.405
-0.005 (-0.11%)
Nov 21, 2024, 2:54 PM EST - Market open
Humacyte Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 20.57 | 80.45 | 149.77 | 217.5 | 39.93 | 93.71 |
Short-Term Investments | - | - | 2.11 | 8 | - | - |
Cash & Short-Term Investments | 20.57 | 80.45 | 151.88 | 225.5 | 39.93 | 93.71 |
Cash Growth | -79.43% | -47.03% | -32.65% | 464.76% | -57.39% | - |
Receivables | - | - | 0.03 | 0.18 | 0.11 | 0.6 |
Prepaid Expenses | 2.29 | 2.69 | 2.3 | 3.66 | 1.41 | 0.64 |
Restricted Cash | 0.14 | 0.14 | - | - | - | - |
Total Current Assets | 23.01 | 83.28 | 154.21 | 229.34 | 41.45 | 94.95 |
Property, Plant & Equipment | 40.26 | 44.1 | 49.41 | 57.19 | 65.24 | 73.74 |
Other Long-Term Assets | 51.5 | 0.84 | 0.68 | - | - | - |
Total Assets | 114.76 | 128.22 | 204.3 | 286.53 | 106.69 | 168.69 |
Accounts Payable | 6.9 | 6.49 | 1.6 | 2.09 | 2.27 | 3.27 |
Accrued Expenses | 11.15 | 9.34 | 7.11 | 6.76 | 4.59 | 6 |
Current Portion of Long-Term Debt | - | - | 8.57 | - | 2.45 | - |
Current Portion of Leases | 2.89 | 2.61 | 2.31 | 2.03 | 1.77 | 1.57 |
Other Current Liabilities | - | - | - | 0.17 | 0.15 | - |
Total Current Liabilities | 20.94 | 18.44 | 19.58 | 11.05 | 11.23 | 10.84 |
Long-Term Debt | 62.37 | 38.67 | 20.34 | 27.36 | 0.82 | - |
Long-Term Leases | 14.38 | 16.87 | 19.45 | 21.79 | 23.82 | 25.65 |
Other Long-Term Liabilities | 80.8 | 40.69 | 28.01 | 104.16 | 0.14 | - |
Total Liabilities | 178.49 | 114.68 | 87.37 | 164.36 | 36.02 | 36.49 |
Common Stock | 0.01 | 0.01 | 0.01 | 0.01 | 0 | 0.02 |
Additional Paid-In Capital | 601.34 | 550.85 | 543.46 | 536.74 | 37.78 | 32.76 |
Retained Earnings | -665.08 | -537.31 | -426.54 | -414.57 | -388.1 | -321.57 |
Total Common Equity | -63.72 | 13.55 | 116.93 | 122.17 | -350.32 | -288.79 |
Shareholders' Equity | -63.72 | 13.55 | 116.93 | 122.17 | 70.67 | 132.2 |
Total Liabilities & Equity | 114.76 | 128.22 | 204.3 | 286.53 | 106.69 | 168.69 |
Total Debt | 79.64 | 58.15 | 50.67 | 51.18 | 28.86 | 27.22 |
Net Cash (Debt) | -59.06 | 22.29 | 101.21 | 174.32 | 11.07 | 66.5 |
Net Cash Growth | - | -77.97% | -41.94% | 1475.03% | -83.36% | - |
Net Cash Per Share | -0.52 | 0.22 | 0.98 | 4.36 | 1.92 | 3.30 |
Filing Date Shares Outstanding | 125.86 | 119.08 | 103.33 | 103 | 22.17 | 20.12 |
Total Common Shares Outstanding | 119.84 | 103.67 | 103.23 | 103 | 22.17 | 20.12 |
Working Capital | 2.06 | 64.84 | 134.63 | 218.29 | 30.22 | 84.11 |
Book Value Per Share | -0.53 | 0.13 | 1.13 | 1.19 | -15.80 | -14.35 |
Tangible Book Value | -63.72 | 13.55 | 116.93 | 122.17 | -350.32 | -288.79 |
Tangible Book Value Per Share | -0.53 | 0.13 | 1.13 | 1.19 | -15.80 | -14.35 |
Machinery | 30.46 | 29.59 | 28.98 | 28.78 | 28.55 | 29.03 |
Construction In Progress | - | - | 0.68 | - | - | - |
Leasehold Improvements | 27.9 | 27.84 | 26.36 | 26.36 | 26.36 | 26.34 |
Source: S&P Capital IQ. Standard template. Financial Sources.